| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 10/21/2004 | US20040209875 Nonsteroidal antiinflammatory agents |
| 10/21/2004 | US20040209863 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents |
| 10/21/2004 | US20040209776 Azole derivatives useful as insecticide |
| 10/21/2004 | DE10316081A1 Neue Verbindungen mit antibakterieller Aktivität New compounds with antibacterial activity |
| 10/21/2004 | CA2521830A1 Heteroaromatic pentacyclic compound and medicinal use thereof |
| 10/21/2004 | CA2521685A1 Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues |
| 10/21/2004 | CA2521653A1 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts |
| 10/21/2004 | CA2521400A1 Piperazine derivative renin inhibitors |
| 10/21/2004 | CA2521340A1 Aminopyrimidine derivatives and their medical use |
| 10/21/2004 | CA2521227A1 Substituted pyrazole compounds |
| 10/21/2004 | CA2521201A1 Substituted pyrazoles for use in the prophylaxis or treatment of a disease which can be influenced by the binding of the substitued pyrazoles to 5ht receptors |
| 10/21/2004 | CA2518916A1 Pi-3 kinase inhibitor prodrugs |
| 10/20/2004 | EP1468996A1 Indole derivatives for the treatment of CNS disorders |
| 10/20/2004 | EP1467992A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones |
| 10/20/2004 | EP1467986A1 Aza-cyclic compounds as modulators of acetylcholine receptors |
| 10/20/2004 | EP1467981A1 4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2 |
| 10/20/2004 | EP1467977A1 Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them. |
| 10/20/2004 | EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 10/20/2004 | EP1467974A1 Benzimidazole derivatives and their use as gnrh antagonists |
| 10/20/2004 | EP1467972A1 Indazole compounds useful as protein kinase inhibitors |
| 10/20/2004 | EP1467971A1 Substituted pyrazolines for use as pesticides |
| 10/20/2004 | EP1467734A1 Cotherapy with an oxazolidinone and a vitamin b |
| 10/20/2004 | EP1467732A1 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases |
| 10/20/2004 | EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 10/20/2004 | EP1467695A2 Hiv integrase inhibitors |
| 10/20/2004 | EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 10/20/2004 | EP0862555B1 Substituted aryl or heteroarylamides having retinoid-like biological activity |
| 10/20/2004 | CN1538969A Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins |
| 10/20/2004 | CN1538968A Novel compounds |
| 10/20/2004 | CN1538967A Heterocyclic compound and antitumour agent containing the same as active ingredient |
| 10/20/2004 | CN1538955A Pyrrolidine derivatives as factor Xa inhibitors |
| 10/20/2004 | CN1538848A Novel Benzo-fused heterocycles |
| 10/20/2004 | CN1538845A Phenyl derivatives as factor Xa inhibitors |
| 10/20/2004 | CN1538836A Substituted amine derivatives and method of use |
| 10/20/2004 | CN1171887C Respiratory syncytial virus replication inhibitors |
| 10/20/2004 | CN1171879C Herbicidal 3-aryl-1,2,4-triazole derivative |
| 10/20/2004 | CN1171872C Compounds for modulation of PPAP gamma activity |
| 10/20/2004 | CN1171582C Oral pharmaceutical extended release dosage form |
| 10/19/2004 | US6806370 NK-1 receptor active amine oxide prodrugs |
| 10/19/2004 | US6806287 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 10/19/2004 | US6806286 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 10/19/2004 | US6806278 Amino-tetralin derivatives as muscarinic receptor antagonists |
| 10/19/2004 | US6806269 Effective at lower concentrations; such as 6-(((1,1-dimethyl-ethoxy)carbonyl)amino)-5-methyl-2-(methyl(phenylmethyl) -amino)-4h-3,1-benzoxazin-4-one |
| 10/19/2004 | US6806230 Pyrimidine derivatives and herbicides containing them |
| 10/19/2004 | CA2296901C Piperidine derivates having anxiolytic effect |
| 10/14/2004 | WO2004087880A2 Compounds and their use to treat diabetes and related disorders |
| 10/14/2004 | WO2004087714A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 10/14/2004 | WO2004087697A1 N-aryl-2-oxazolidinone-5-carboxamides derivatives with antibacterial activity |
| 10/14/2004 | WO2004087696A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 10/14/2004 | WO2004087695A1 Method for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products |
| 10/14/2004 | WO2004087694A1 A heterocycle-substituted benzoxazine compounds having bioactivity |
| 10/14/2004 | WO2004087690A2 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex |
| 10/14/2004 | WO2004087680A1 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 10/14/2004 | WO2004087669A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof |
| 10/14/2004 | WO2004087647A2 4-substituted quinolein derivatives with antimicrobial activity |
| 10/14/2004 | WO2004087646A2 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
| 10/14/2004 | WO2004087641A1 Hydrazone derivative |
| 10/14/2004 | WO2004087051A2 Ophthalmic compositions for treating ocular hypertension |
| 10/14/2004 | WO2004078116A3 P38 inhibitors and methods of use thereof |
| 10/14/2004 | WO2004056727A3 Process of making chalcone derivatives |
| 10/14/2004 | WO2004050636A3 IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 10/14/2004 | WO2004037176A3 Quinazolinones and derivatives thereof as factor xa inhibitors |
| 10/14/2004 | WO2004024939A3 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof |
| 10/14/2004 | WO2004004655A3 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 10/14/2004 | US20040204591 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 10/14/2004 | US20040204588 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones |
| 10/14/2004 | US20040204586 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 10/14/2004 | US20040204500 Preventives/remedies for organ functional disorders and organ dysfunction |
| 10/14/2004 | US20040204498 Pyrimidine carboxamides; 5-hydroxy-2-(2-(1,1-Dioxo-6-[1,2]thiazinan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides; AIDS; AIDS related complex |
| 10/14/2004 | US20040204477 For use as antiproliferative agents |
| 10/14/2004 | US20040204463 Aantimicrobials with activity against human and veterinary pathogens: Gram-positive aerobic bacteria multiply-resistant staphylococci and streptococci, anaerobic organisms bacteroides and clostridia and acid-fast organisms such as Mycobacterium |
| 10/14/2004 | US20040204462 E.g., l2-{3-[2-(4-Fluorophenyl)oxazol-4-ylmethoxy]cyclohexyloxy}-6-methylbenzoic acid; lipid- and/or triglyceride-lowering properties; metabolic disorders; antidiabetic agents (type II); therapy of syndrome X; eating disorders; cardiomyopathy |
| 10/14/2004 | US20040204461 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 10/14/2004 | US20040204454 Lactam-containing cyclic diamines and derivatives as factor Xa inhibitors |
| 10/14/2004 | US20040204452 to decompose peroxynitrite anion into harmless nitrate or nitrite endproducts which prevents the free radical-mediated cell damage; cytoprotective; Alzheimer's disease; 3,5-dimethylisoxazole-4-sulfonic acid 4-pyrrolidin-1-ylphenylamide |
| 10/14/2004 | US20040204450 For therapy of atherosclerosis, coronary artery disease, coronary heart disease, coronary vascular disease, peripheral vascular disease, dyslipidemia, hyperbetalipoproteinemia, hypoalphalipoproteinemia, hypercholesterolemia, hypertriglyceridemia, familial-hypercholesterolemia |
| 10/14/2004 | US20040204437 Substituted arylamine derivatives and methods of use |
| 10/14/2004 | US20040204421 Certain 1,3-disubstituted isoquinoline derivatives |
| 10/14/2004 | US20040204417 For therapy of cancer |
| 10/14/2004 | US20040204410 Such as 1-(4,5-Bis-(4-chloro-phenyl)-2-(2,4-dimethoxy-phenyl)-4,5-dihydro-imidazol-1-yl)-2-methyl-propan-1-one which inhibits the interaction of MDM2 protein with p53-like peptide; antiproliferative agents |
| 10/14/2004 | US20040204408 Piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 10/14/2004 | US20040204406 Pyrazole-derivatives as factor Xa inhibitors |
| 10/14/2004 | US20040204386 for uses such as inhibiting the activity of lysophosphatidic acid acyltransferase beta and/or inhibiting the proliferation of a cell (e.g., tumor cell) |
| 10/14/2004 | DE10315572A1 Substituierte Pyrazole Substituted pyrazoles |
| 10/14/2004 | DE10315570A1 New 1-aryl-1,2,3-triazole derivatives useful for treating e.g. schizophrenia, depression, dementia, Parkinson's disease or Alzheimer's disease, are glycine transporter inhibitors |
| 10/14/2004 | DE10315569A1 Substituierte Pyrazolverbindungen Substituted pyrazole |
| 10/14/2004 | DE10315377A1 New carbonyl-substituted carbocyclic or heterocyclic compounds, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation or tumors |
| 10/14/2004 | CA2521056A1 Hydrazone derivative |
| 10/14/2004 | CA2520896A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 10/14/2004 | CA2520894A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 10/14/2004 | CA2520764A1 4-substituted quinolein derivatives with antimicrobial activity |
| 10/14/2004 | CA2520723A1 N-aryl-2-oxazolidinone-5-carboxamides derivatives with antibacterial activity |
| 10/14/2004 | CA2520281A1 Benzimidazole derivatives and their use for modulating the gabaa recept or complex |
| 10/14/2004 | CA2519899A1 Ophthalmic compositions for treating ocular hypertension |
| 10/14/2004 | CA2518913A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof |
| 10/14/2004 | CA2518465A1 Dipeptidyl peptidase inhibitors |
| 10/13/2004 | EP1466902A1 Androgen receptor antagonists |
| 10/13/2004 | EP1466901A1 Serotonine reuptake inhibitor |
| 10/13/2004 | EP1465892A1 Glycinamides as factor xa inhibitors |
| 10/13/2004 | EP1465872A1 4-sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |